Assessment of Basal Cell Carcinoma Using Dermoscopy and High Frequency Ultrasound Examination
- PMID: 35328289
- PMCID: PMC8947530
- DOI: 10.3390/diagnostics12030735
Assessment of Basal Cell Carcinoma Using Dermoscopy and High Frequency Ultrasound Examination
Abstract
Basal cell carcinoma (BCC) is the most common form of cutaneous neoplasia in humans, and dermoscopy may provide valuable information for histopathological classification of BCC, which allows for the choice of non-invasive topical or surgical therapy. Similarly, dermoscopy may allow for the identification of incipient forms of BCC that cannot be detected in clinical examination. The importance of early diagnosis using the dermoscopy of superficial BCC forms is proven by the fact that despite their indolent clinical appearance, they can be included in high-risk BCC forms due to the rate of postoperative recurrence. Nodular pigmentary forms of BCCs present ovoid gray-blue nests or multiple gray-blue dots/globules associated with arborized vessels, sometimes undetectable on clinical examination. The management of BCC depends on this, as pigmentary forms have been shown to have a poor response to photodynamic therapy. High frequency ultrasound examination (HFUS) aids in the diagnosis of BCC with hypoechoic tumour masses, as well as in estimating tumour size (thickness and diameter), presurgical margin delineation, and surgical planning. The examination is also useful for determining the invasion of adjacent structures and for studying local recurrences. The use of dermoscopy in combination with HFUS allows for optimisation of the management of the oncological patient.
Keywords: basal cell carcinoma; dermoscopy; high frequency ultrasound examination.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Dermoscopy uncovers clinically undetectable pigmentation in basal cell carcinoma.Br J Dermatol. 2014 Jan;170(1):192-5. doi: 10.1111/bjd.12634. Br J Dermatol. 2014. PMID: 24117444
-
Dermoscopic features of basal cell carcinoma and its subtypes: A systematic review.J Am Acad Dermatol. 2021 Sep;85(3):653-664. doi: 10.1016/j.jaad.2019.11.008. Epub 2019 Nov 7. J Am Acad Dermatol. 2021. PMID: 31706938 Free PMC article.
-
Basal cell carcinoma thickness evaluated by high-frequency ultrasounds and correlation with dermoscopic features.Ital J Dermatol Venerol. 2021 Oct;156(5):610-615. doi: 10.23736/S2784-8671.20.06576-1. Epub 2020 Sep 17. Ital J Dermatol Venerol. 2021. PMID: 32938160
-
Dermoscopy of Basal Cell Carcinoma Part 3: Differential Diagnosis, Treatment Monitoring and Novel Technologies.Cancers (Basel). 2025 Mar 19;17(6):1025. doi: 10.3390/cancers17061025. Cancers (Basel). 2025. PMID: 40149358 Free PMC article. Review.
-
Dermoscopic criteria and basal cell carcinoma.G Ital Dermatol Venereol. 2012 Apr;147(2):135-40. G Ital Dermatol Venereol. 2012. PMID: 22481576 Review.
Cited by
-
Non-invasive imaging techniques in presurgical margin assessment of basal cell carcinoma: Current evidence.Skin Res Technol. 2023 Feb;29(2):e13271. doi: 10.1111/srt.13271. Skin Res Technol. 2023. PMID: 36823508 Free PMC article.
-
Dermoscopy, reflectance confocal microscopy, and high-frequency ultrasound for the noninvasive diagnosis of morphea-form basal cell carcinoma.Skin Res Technol. 2022 Sep;28(5):766-768. doi: 10.1111/srt.13197. Epub 2022 Jul 24. Skin Res Technol. 2022. PMID: 35871487 Free PMC article. No abstract available.
-
Advances in Skin Ultrasonography for Malignant and Benign Tumors of the Head and Neck: Current Insights and Future Directions.J Clin Med. 2025 Mar 27;14(7):2298. doi: 10.3390/jcm14072298. J Clin Med. 2025. PMID: 40217748 Free PMC article. Review.
-
Basal Cell Carcinoma: Comprehensive Review with Emphasis on Scar Tissue Manifestation and Post-Vaccination Incidence.Biomedicines. 2024 Aug 6;12(8):1769. doi: 10.3390/biomedicines12081769. Biomedicines. 2024. PMID: 39200233 Free PMC article. Review.
-
Preliminary Experience in Ultra-High Frequency Ultrasound Assessment of Cutaneous Primary Lymphomas: An Innovative Classification.Cancers (Basel). 2024 Jul 4;16(13):2456. doi: 10.3390/cancers16132456. Cancers (Basel). 2024. PMID: 39001518 Free PMC article.
References
-
- Gheuca Solovastru L., Vata D., Statescu L., Constantin M., Andrese E. Skin cancer between myth and Reality, yet ethically constrained. Rev. Rom. Bioet. 2014;12:47–52.
-
- Brasseur R., Lagesse C. Contribution of psychometry of clinical evaluation of the therapeutic effect of “Solcoseryl” in states of intellectual weakness connected with chronic cerebral circulatory insufficiency (author’s transl) Schweiz. Rundsch. Med. Prax. 1977;66:312–317. - PubMed
Publication types
LinkOut - more resources
Full Text Sources